We are live on ! Find out more
GCM

Geneva Capital Management Portfolio holdings

AUM $4.36B
1-Year Est. Return 17.81%
This Fund
S&P 500
This Quarter Est. Return
+7.13%
1 Year Est. Return
+17.81%
3 Year Est. Return
+59.44%
5 Year Est. Return
+75.65%
10 Year Est. Return
AUM
$5.97B
AUM Growth
+$618M
Cap. Flow
+$349M
Cap. Flow %
5.84%
Top 10 Hldgs %
30.3%
Holding
127
New
2
Increased
97
Reduced
24
Closed
4

Top Buys

Rank Stock Value
1
RGEN icon
Repligen
RGEN
+$43.8M
2
VERX icon
Vertex
VERX
+$37.1M
3
VVV icon
Valvoline
VVV
+$24.3M
4
MTSI icon
MACOM Technology Solutions
MTSI
+$20.1M
5
VCEL icon
Vericel Corp
VCEL
+$17.4M

Top Sells

Rank Stock Value
1
KNSL icon
Kinsale Capital Group
KNSL
+$30.1M
2
ROAD icon
Construction Partners
ROAD
+$27.5M
3
NVEE
NV5 Global
NVEE
+$17.7M
4
NEOG icon
Neogen
NEOG
+$17.4M
5
DV icon
DoubleVerify
DV
+$12.3M

Sector Composition

Rank Sector Weight
1 Technology 34.2%
2 Industrials 27.7%
3 Healthcare 12.74%
4 Consumer Discretionary 9.09%
5 Financials 6.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCHP icon
126
Microchip Technology
MCHP
$46B
-11,108
Closed -$538K
NEOG icon
127
Neogen
NEOG
$2.5B
-2,011,415
Closed -$17.4M

Similar funds

Geneva Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Geneva Capital Management held 127 positions worth $5.97B, up 12% from $5.35B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Geneva Capital Management deployed $349M of net new capital in Q2 2025, opening 2 new positions and adding to 97 existing holdings. Its largest new stake was MACOM Technology Solutions: 172,230 shares worth $24.7M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Kinsale Capital Group, an estimated $30.1M trimmed.

  • Geneva Capital Management's largest Q2 2025 buy was MACOM Technology Solutions: 172,230 shares worth $24.7M.
  • Geneva Capital Management added most to Repligen in Q2 2025, an estimated $43.8M increase.
  • Geneva Capital Management's biggest Q2 2025 reduction was Kinsale Capital Group, cutting an estimated $30.1M.
  • Geneva Capital Management fully exited Neogen in Q2 2025, selling an estimated $17.4M.
  • Geneva Capital Management's ten largest holdings make up 30% of its $5.97B portfolio in Q2 2025.
  • Geneva Capital Management opened 2 new positions and closed 4 in Q2 2025.
  • Geneva Capital Management's portfolio value rose 12% quarter-over-quarter to $5.97B.

Based on Geneva Capital Management's 13F filing for Q2 2025, filed 5 Aug 2025.